At RSNA 2023, Lunit will display seven AI studies aimed at enhancing diagnostic efficiency in chest radiography and breast cancer risk evaluation. The presentations will showcase advancements like AI algorithms that improve the accuracy…
Continue Reading
Dr. Robert Bard, a leader in radiological diagnostics, advocates for 3D Doppler imaging’s role in non-invasive cancer detection, particularly in breast, prostate, and skin cancers. Highlighting its precision and the reduced need for biopsies,…
Continue Reading
A new PET-CT scanner has been launched at Norfolk and Norwich University Hospital, to boost access to advanced cancer diagnostics in the East of England.The hospital has advanced its onsite PET-CT service, thanks to…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Led by 83North, This Round of Financing Brings Total Funding to Over $100 Million
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round…
Lunit’s AI-powered solution, SCOPE IO, is transforming breast cancer care by improving the assessment of tumor-infiltrating lymphocytes (TILs). In a groundbreaking study, SCOPE IO demonstrated remarkable concordance with pathologists’ evaluations, reducing discordant cases significantly….
Continue Reading
What You Should Know: – Ibex Medical Analytics (Ibex), a provider of AI-powered cancer diagnostics raises $55M in Series C financing round led by 83North. – The round also included participation from Sienna Venture Capital and existing…
Continue Reading
